Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
IL-2 assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-6 assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-7 assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Mononuclear cell function assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-3 assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Cytokine assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon gamma assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Intracellular free calcium assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
TNF, Beta assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Interleukin-8 assay (procedure) |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Protein kinase C activity assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alpha assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Lymphokine assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon beta assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-4 assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-5 assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
Tumor necrosis factor assay |
Has measured component (attribute) |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-2 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-6 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-7 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
Mononuclear cell function assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
2 |
IL-3 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
Cytokine assay |
Component |
True |
Cytokine |
Inferred relationship |
Some |
1 |
Interferon gamma assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
Intracellular free calcium assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
2 |
TNF, Beta assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
Interleukin-8 assay (procedure) |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
Protein kinase C activity assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
3 |
Interferon alpha assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
Lymphokine assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
3 |
Interferon assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon beta assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-4 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
IL-5 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
Tumor necrosis factor assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
Product containing interferon gamma-1b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Product containing interferon beta-1a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Product containing interferon beta-1b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Product containing interferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Product containing interferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Product containing cytokine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytokine |
Inferred relationship |
Some |
1 |
Product containing aldesleukin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Product containing peginterferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon beta-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Product containing interferon gamma (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Human interferon gamma-1b 200 micrograms/mL injection solution 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 10million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 5million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 3million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 1million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 6million iu/mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 18million iu/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon beta-1b 8million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 1million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 4.5million iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 5million units injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 10million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 30million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 3million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 9million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 18million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 3million iu/1mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons 10million iu/1mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferons (2) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 6million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 9million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 12million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 18million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon beta-1a 6million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 15million iu/1mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 25million iu/1mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 50million iu/1mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 10million iu/mL injection solution 2.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon beta-1a 12million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon beta-1a 24million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 18million iu/0.6mL injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Peginterferon alfa-2b 50micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Peginterferon alfa-2b 150micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Peginterferon alfa-2b 120micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Product containing interferon alfa-n1 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Aldesleukin 18megaunits powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 30000000iu solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 60million/iu solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 150mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 300mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 120mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 600mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 100.000mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2b 50mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-n3 human leu 5000000unt/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 18000000iu/3mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 36000000iu/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 3miu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 6miu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfa-2a 9miu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon alfacon-130mcg/mL injection solution 0.3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
Interferon beta-1b 100mcg injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|